Literature DB >> 24603891

Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9.

Wei Sun1, Dong-Bo Liu1, Wen-Wen Li1, Lin-Li Zhang1, Guo-Xian Long1, Jun-Feng Wang1, Qi Mei1, Guo-Qing Hu1.   

Abstract

Nasopharyngeal carcinoma (NPC) shows the highest invasive and metastatic features among head and neck cancers. Distant metastasis remains the predominant mode of treatment failure in NPC patients. The role of interleukin-6 (IL-6) in NPC progression is not fully understood. In this study, we explored whether IL-6 could promote the migration and invasion activity of NPC cell lines, as well as whether the effect of IL-6 on cell migration and invasion is mediated through regulating the expression of matrix metalloproteinase-2 (MMP-2) and MMP-9. Our results revealed that IL-6 and its receptors are broadly expressed in various NPC cell lines including HNE1, HONE1, CNE1, CNE1-LMP1 and 5-8F. Exogenous IL-6 enhanced cell proliferation slightly, but promoted cell migration and invasion significantly in both HNE1 and CNE1-LMP1 cell lines. In addition, an elevation in the expression of MMP-2 and MMP-9 could be induced by IL-6 stimulation. On the contrary, combining treatment with monoclonal anti-human IL-6R antibody (anti-IL-6R mAb) resulted in decreased proliferation, migration and invasion capabilities of NPC cells. Anti-IL-6R mAb also inhibited the expression of MMP-2 and MMP-9 in IL-6-stimulated HNE1 and CNE1-LMP1 cells. In summary, our data suggested that IL-6 mainly promotes the cell migration and invasion of NPC cells. The effect of IL-6 on cell migration and invasion may be mediated through regulation of the expression of MMP-2 and MMP-9. Thus, IL-6 or its related signaling pathways may be a promising target for preventing and inhibiting NPC metastasis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24603891     DOI: 10.3892/ijo.2014.2323

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  32 in total

1.  Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition.

Authors:  Jipei Liao; Zejia Yang; Brandon Carter-Cooper; Elizabeth T Chang; Eun Yong Choi; Bhaskar Kallakury; Xuefeng Liu; Rena G Lapidus; Kevin J Cullen; Hancai Dan
Journal:  Clin Exp Metastasis       Date:  2020-02-04       Impact factor: 5.150

2.  Curcumin suppresses migration and invasion of human endometrial carcinoma cells.

Authors:  Qian Chen; Qing Gao; Kunlun Chen; Yidong Wang; Lijuan Chen; X U Li
Journal:  Oncol Lett       Date:  2015-07-09       Impact factor: 2.967

Review 3.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

4.  Necrosis Factor-α (TNF-α) and the Presence of Macrophage M2 and T Regulatory Cells in Nasopharyngeal Carcinoma.

Authors:  Iffah Mardhiyah; Yustina Nuke Ardiyan; Siti Hamidatul Aliyah; Enda Cindylosa Sitepu; Camelia Herdini; Ery Kus Dwianingsih; Fatin Asfarina; Sumartiningsih Sumartiningsih; Jajah Fachiroh; Dewi Kartikawati Paramita
Journal:  Asian Pac J Cancer Prev       Date:  2021-08-01

5.  Epstein-Barr virus-induced ectopic CD137 expression helps nasopharyngeal carcinoma to escape immune surveillance and enables targeting by chimeric antigen receptors.

Authors:  Mukul Prasad; Sashigala Ponnalagu; Qun Zeng; Khang Luu; Si Min Lang; Hiu Yi Wong; Man Si Cheng; Meihui Wu; Karthik Mallilankaraman; Radoslaw Mikolaj Sobota; Yan Ting Lim; Loo Chien Wang; Chuan Keng Goh; Kai Xun Joshua Tay; Kwok Seng Loh; Cheng-I Wang; Wen-Hsien Lee; Boon Cher Goh; Chwee Ming Lim; Herbert Schwarz
Journal:  Cancer Immunol Immunother       Date:  2022-03-17       Impact factor: 6.630

6.  Next-generation Tumor-homing Induced Neural Stem Cells as an Adjuvant to Radiation for the Treatment of Metastatic Lung Cancer.

Authors:  Alison R Mercer-Smith; Andrew Buckley; Alain Valdivia; Wulin Jiang; Morrent Thang; Noah Bell; Rashmi J Kumar; Hunter N Bomba; Alex S Woodell; Jie Luo; Scott R Floyd; Shawn D Hingtgen
Journal:  Stem Cell Rev Rep       Date:  2022-04-19       Impact factor: 6.692

7.  Immunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis.

Authors:  Fu Sang Luk; Roy Y Kim; Kang Li; Daniel Ching; David K Wong; Sunil K Joshi; Isabella Imhof; Norman Honbo; Holly Hoover; Bo-Qing Zhu; David H Lovett; Joel S Karliner; Robert L Raffai
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

8.  IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.

Authors:  Ahmed-Amine Zergoun; Abderezak Zebboudj; Sarah Leila Sellam; Nora Kariche; Djamel Djennaoui; Samir Ouraghi; Esma Kerboua; Zine-Charaf Amir-Tidadini; Dalia Chilla; Fatima Asselah; Chafia Touil-Boukoffa; Taha Merghoub; Mehdi Bourouba
Journal:  Tumour Biol       Date:  2015-10-09

9.  Cancer Conditioned Medium Modulates Functional and Phenotypic Properties of Human Decidua Parietalis Mesenchymal Stem/Stromal Cells.

Authors:  E Bahattab; T Khatlani; F M Abomaray; S A Messaoudi; M H Abumaree
Journal:  Tissue Eng Regen Med       Date:  2019-11-01       Impact factor: 4.169

10.  Investigation of Fascin1, a Marker of Mature Dendritic Cells, Reveals a New Role for IL-6 Signaling in CCR7-Mediated Chemotaxis.

Authors:  Fumio Matsumura; Robin Polz; Sukhwinder Singh; Aya Matsumura; Jürgen Scheller; Shigeko Yamashiro
Journal:  J Immunol       Date:  2021-07-23       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.